Serum GPC3 is reported to be detectable in 40 to 53% of HCC patients, in approximately one third of patients with normal AFP levels16, 17, 18, and undetectable in healthy donors16, 18. The gene discussed is GPC3; the disease is hepatocellular carcinoma.